AJP - Renal Ad Instruments
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Am J Physiol Renal Physiol 294: F336-F344, 2008. First published December 12, 2007; doi:10.1152/ajprenal.00500.2007
0363-6127/08 $8.00
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
294/2/F336    most recent
00500.2007v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Web of Science (9)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Quiroz, Y.
Right arrow Articles by Rodriguez-Iturbe, B.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Quiroz, Y.
Right arrow Articles by Rodriguez-Iturbe, B.

Melatonin ameliorates oxidative stress, inflammation, proteinuria, and progression of renal damage in rats with renal mass reduction

Yasmir Quiroz,1 Atilio Ferrebuz,1 Freddy Romero,1 Nosratola D. Vaziri,3 and Bernardo Rodriguez-Iturbe1,2

1Centro de Investigaciones Biomédicas, Instituto Venezolano de Investigaciones Científicas-Zulia and 2Renal Service Hospital Universitario and Universidad del Zulia, Maracaibo, Venezuela; and 3Division of Nephrology and Hypertension, Department of Medicine, University of California, Irvine, California

Submitted 24 October 2007 ; accepted in final form 11 December 2007

The progressive deterioration of renal function and structure resulting from renal mass reduction are mediated by a variety of mechanisms, including oxidative stress and inflammation. Melatonin, the major product of the pineal gland, has potent_antioxidant and anti-inflammatory properties, and its production is impaired in chronic renal failure. We therefore investigated if melatonin treatment would modify the course of chronic renal failure in the remnant kidney model. We studied rats followed 12 wk after renal ablation untreated (Nx group, n = 7) and treated with melatonin administered in the drinking water (10 mg/100 ml) (Nx + MEL group, n = 8). Sham-operated rats (n = 10) were used as controls. Melatonin administration increased 13–15 times the endogenous hormone levels. Rats in the Nx + MEL group had reduced oxidative stress (malondialdehyde levels in plasma and in the remnant kidney as well as nitrotyrosine renal abundance) and renal inflammation (p65 nuclear factor-{kappa}B-positive renal interstitial cells and infiltration of lymphocytes and macrophages). Collagen, {alpha}-smooth muscle actin, and transforming growth factor-β renal abundance were all increased in the remnant kidney of the untreated rats and were reduced significantly by melatonin treatment. Deterioration of renal function (plasma creatinine and proteinuria) and structure (glomerulosclerosis and tubulointerstitial damage) resulting from renal ablation were ameliorated significantly with melatonin treatment. In conclusion, melatonin administration improves the course of chronic renal failure in rats with renal mass reduction. Further studies are necessary to define the potential usefulness of this treatment in other animal models and in patients with chronic renal disease.

oxidative stress; renal inflammation; renal ablation; renal failure; melatonin; antioxidants



Address for reprint requests and other correspondence: B. Rodríguez-Iturbe, Renal Service Hospital Universitario, Ave Goajira S/N. Maracaibo, Zulia 4001-A, Veneuela (e-mail: bri{at}iamnet.com)




This article has been cited by other articles:


Home page
Nephrol Dial TransplantHome page
M. A. Aminzadeh, M. V. Pahl, C. H. Barton, N. S. Doctor, and N. D. Vaziri
Human uraemic plasma stimulates release of leptin and uptake of tumour necrosis factor-{alpha} in visceral adipocytes
Nephrol. Dial. Transplant., December 1, 2009; 24(12): 3626 - 3631.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Renal Physiol.Home page
W. S. An, H. J. Kim, K.-H. Cho, and N. D. Vaziri
Omega-3 fatty acid supplementation attenuates oxidative stress, inflammation, and tubulointerstitial fibrosis in the remnant kidney
Am J Physiol Renal Physiol, October 1, 2009; 297(4): F895 - F903.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Renal Physiol.Home page
S. S. Ghosh, H. D. Massey, R. Krieg, Z. A. Fazelbhoy, S. Ghosh, D. A. Sica, I. Fakhry, and T. W. B. Gehr
Curcumin ameliorates renal failure in 5/6 nephrectomized rats: role of inflammation
Am J Physiol Renal Physiol, May 1, 2009; 296(5): F1146 - F1157.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Visit Other APS Journals Online
Copyright © 2008 by the American Physiological Society.